The PD-L1 gene (CD274) was also identified in our network analysis as being targeted by miR-200a, which we had previously demonstrated was characteristically down-regulated in ccRCC [50], and that was down-regulated in both 786-O and Caki-1-resistant clones (but not A498 cells). This evidence concerns the gene CD274 and nonpapillary renal cell carcinoma.